Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $50.75 million. The enterprise value is $50.09 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 33.83 million shares outstanding. The number of shares has increased by 5.04% in one year.
| Current Share Class | 33.83M |
| Shares Outstanding | 33.83M |
| Shares Change (YoY) | +5.04% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 19.54% |
| Owned by Institutions (%) | 8.14% |
| Float | 16.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 95.12 |
| P/TBV Ratio | 105.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.38 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11,606.13 |
Financial Efficiency
Return on equity (ROE) is -1,569.59% and return on invested capital (ROIC) is -882.19%.
| Return on Equity (ROE) | -1,569.59% |
| Return on Assets (ROA) | -686.94% |
| Return on Invested Capital (ROIC) | -882.19% |
| Return on Capital Employed (ROCE) | -3,347.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.79M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -66.37% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 2.57 |
| Relative Strength Index (RSI) | 48.74 |
| Average Volume (20 Days) | 4,521,131 |
Short Selling Information
The latest short interest is 1.31 million, so 3.88% of the outstanding shares have been sold short.
| Short Interest | 1.31M |
| Short Previous Month | 1.89M |
| Short % of Shares Out | 3.88% |
| Short % of Float | 7.79% |
| Short Ratio (days to cover) | 0.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.11M |
| Pretax Income | -16.08M |
| Net Income | -16.08M |
| EBITDA | n/a |
| EBIT | -16.11M |
| Earnings Per Share (EPS) | -$0.54 |
Full Income Statement Balance Sheet
The company has $754,323 in cash and $93,432 in debt, giving a net cash position of $660,891 or $0.02 per share.
| Cash & Cash Equivalents | 754,323 |
| Total Debt | 93,432 |
| Net Cash | 660,891 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 481,223 |
| Book Value Per Share | 0.02 |
| Working Capital | 481,223 |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -3.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |